Hyperfine, Inc. (HYPR)
USD 0.69
(-6.01%)
USD 0.69
(-6.01%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 52.87 Million USD | -29.3% |
| 2022 | 74.78 Million USD | 17.39% |
| 2021 | 63.7 Million USD | 176.79% |
| 2020 | 23.01 Million USD | 15.25% |
| 2019 | 19.96 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 12.64 Million USD | 5.37% |
| 2024 Q1 | 12 Million USD | -5.2% |
| 2023 Q3 | 12.88 Million USD | -1.93% |
| 2023 FY | 52.87 Million USD | -29.3% |
| 2023 Q1 | 14.19 Million USD | 1.87% |
| 2023 Q4 | 12.66 Million USD | -1.71% |
| 2023 Q2 | 13.13 Million USD | -7.43% |
| 2022 Q2 | 23.02 Million USD | -3.47% |
| 2022 Q4 | 13.92 Million USD | -0.29% |
| 2022 Q3 | 13.97 Million USD | -39.33% |
| 2022 FY | 74.78 Million USD | 17.39% |
| 2022 Q1 | 23.85 Million USD | -6.94% |
| 2021 FY | 63.7 Million USD | 176.79% |
| 2021 Q4 | 25.63 Million USD | 59.69% |
| 2021 Q3 | 16.05 Million USD | 10.8% |
| 2021 Q2 | 14.48 Million USD | 92.44% |
| 2021 Q1 | 7.52 Million USD | 12.97% |
| 2020 Q2 | 5.26 Million USD | 0.0% |
| 2020 Q1 | 5.26 Million USD | 0.0% |
| 2020 Q3 | 5.81 Million USD | 10.31% |
| 2020 Q4 | 6.66 Million USD | 14.66% |
| 2020 FY | 23.01 Million USD | 15.25% |
| 2019 FY | 19.96 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -371.062% |
| Cerus Corporation | 143.15 Million USD | 63.067% |
| OrthoPediatrics Corp. | 137.01 Million USD | 61.413% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -365.387% |
| Talis Biomedical Corporation | 67.18 Million USD | 21.305% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -111.946% |
| Inogen, Inc. | 236.08 Million USD | 77.605% |
| Spectral AI, Inc. | 20.86 Million USD | -153.413% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 5.581% |
| CVRx, Inc. | 76.14 Million USD | 30.561% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1398.641% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -323.349% |
| Orthofix Medical Inc. | 667.42 Million USD | 92.078% |
| Venus Concept Inc. | 80.47 Million USD | 34.301% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 6.55% |
| Bioventus Inc. | 409.91 Million USD | 87.102% |
| BrainsWay Ltd. | 28.01 Million USD | -88.707% |
| Envoy Medical, Inc. | 17.89 Million USD | -195.407% |
| electroCore, Inc. | 32.03 Million USD | -65.065% |
| IceCure Medical Ltd | 16.87 Million USD | -213.297% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -24.604% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -199.846% |
| MaxCyte, Inc. | 84.84 Million USD | 37.684% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -325.983% |
| Nexalin Technology, Inc. | 5.78 Million USD | -814.526% |
| PAVmed Inc | 64.82 Million USD | 18.441% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -3.512% |
| RxSight, Inc. | 103.85 Million USD | 49.088% |
| Sight Sciences, Inc. | 126.44 Million USD | 58.187% |
| SI-BONE, Inc. | 156.35 Million USD | 66.184% |
| TELA Bio, Inc. | 84.18 Million USD | 37.197% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 24.529% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 74.001% |
| LivaNova PLC | 843.54 Million USD | 93.732% |
| 908 Devices Inc. | 68.08 Million USD | 22.338% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 89.067% |
| Nemaura Medical Inc. | 7.13 Million USD | -640.628% |
| NeuroPace, Inc. | 75.29 Million USD | 29.781% |
| LENSAR, Inc. | 33.33 Million USD | -58.603% |
| Apyx Medical Corporation | 51.01 Million USD | -3.634% |
| Cutera, Inc. | 197.72 Million USD | 73.26% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -113.357% |
| BioSig Technologies, Inc. | 28.53 Million USD | -85.321% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 72.387% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -46.622% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 93.679% |
| Axonics, Inc. | 270.2 Million USD | 80.432% |
| Outset Medical, Inc. | 198.77 Million USD | 73.4% |
| IRIDEX Corporation | 31.81 Million USD | -66.191% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 70.662% |
| IRadimed Corporation | 30.12 Million USD | -75.521% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -519.691% |
| INVO Bioscience, Inc. | 7.85 Million USD | -573.246% |
| Telesis Bio, Inc. | 63.48 Million USD | 16.723% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 46.297% |
| Varex Imaging Corporation | 224.8 Million USD | 76.48% |
| Quipt Home Medical Corp. | 148.66 Million USD | 64.436% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -351.011% |
| Pulmonx Corporation | 112.68 Million USD | 53.081% |
| Dynatronics Corporation | 9.9 Million USD | -433.628% |
| Modular Medical, Inc. | 17.52 Million USD | -201.626% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -161.911% |
| Semler Scientific, Inc. | 38.94 Million USD | -35.764% |
| InMode Ltd. | 215.68 Million USD | 75.486% |
| Bruker Corporation | 1.07 Billion USD | 95.088% |
| Cytosorbents Corporation | 48.33 Million USD | -9.382% |
| DexCom, Inc. | 1.69 Billion USD | 96.874% |
| Align Technology, Inc. | 2.07 Billion USD | 97.454% |
| Viveve Medical, Inc. | 22.17 Million USD | -138.452% |
| ZimVie Inc. | 275.12 Million USD | 80.783% |
| Movano Inc. | 29.69 Million USD | -78.08% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 61.483% |
| Nexalin Technology, Inc. | 5.78 Million USD | -814.526% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1398.641% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 91.201% |
| Profound Medical Corp. | 33.6 Million USD | -57.342% |
| Insulet Corporation | 939.9 Million USD | 94.375% |
| enVVeno Medical Corporation | 25.23 Million USD | -109.494% |
| Surmodics, Inc. | 98.69 Million USD | 46.43% |
| iCAD, Inc. | 22.22 Million USD | -137.894% |
| Nuwellis, Inc. | 22.61 Million USD | -133.812% |
| Biotricity, Inc. | 17.18 Million USD | -207.672% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 88.142% |
| Aethlon Medical, Inc. | 12.27 Million USD | -330.641% |
| InspireMD, Inc. | 22.95 Million USD | -130.379% |
| PAVmed Inc. | 64.82 Million USD | 18.441% |
| BIOLASE, Inc. | 34.66 Million USD | -52.54% |
| Beyond Air, Inc. | 61.7 Million USD | 14.308% |
| FONAR Corporation | 28.6 Million USD | -84.837% |
| AxoGen, Inc. | 149.33 Million USD | 64.595% |
| Vivani Medical, Inc. | 26.96 Million USD | -96.076% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 70.144% |
| Inari Medical, Inc. | 448.59 Million USD | 88.214% |
| UFP Technologies, Inc. | 58.08 Million USD | 8.981% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -972.977% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -736.809% |
| Tenon Medical, Inc. | 16.96 Million USD | -211.598% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -615.163% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -19.883% |
| AdaptHealth Corp. | 1.07 Billion USD | 95.095% |
| Sintx Technologies, Inc. | 15.2 Million USD | -247.819% |
| NanoVibronix, Inc. | 4.97 Million USD | -963.181% |
| Quanterix Corporation | 118.1 Million USD | 55.231% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -351.011% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -266.099% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 86.535% |
| TransMedics Group, Inc. | 182.82 Million USD | 71.08% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -88.391% |
| NeuroMetrix, Inc. | 11.09 Million USD | -376.37% |
| Establishment Labs Holdings Inc. | 172 Million USD | 69.261% |
| Biomerica, Inc. | 6.97 Million USD | -657.696% |
| Bone Biologics Corporation | 9.42 Million USD | -460.78% |
| AVITA Medical, Inc. | 80.77 Million USD | 34.548% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -412.762% |
| Silk Road Medical, Inc | 186.35 Million USD | 71.629% |